You have 9 free searches left this month | for more free features.

Statin

Showing 1 - 25 of 1,801

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Drug Adherence Trial (Red yeast rice extract initial therapy followed later on by statin therapy, Statin therapy)

Not yet recruiting
  • Moderate 10-year Atherosclerotic Cardiovascular Disease Risk Patients
  • Red yeast rice extract initial therapy followed later on by statin therapy
  • Statin therapy
  • (no location specified)
Apr 26, 2023

Vaccine Response Trial in Atlanta (Atorvastatin, Quadrivalent seasonal influenza vaccine)

Not yet recruiting
  • Vaccine Response
  • Atlanta, Georgia
    Hope Clinic
Aug 29, 2023

Coronary Artery Disease Requiring Coronary Revascularization With Newer Generation DES Implantation Trial in Seoul

Not yet recruiting
  • Coronary Artery Disease Requiring Coronary Revascularization With Newer Generation DES Implantation
  • ezetimibe/high-intensity statin combination therapy (ezetimibe 10mg plus atoravastatin 40mg)
  • high-intensity statin monotherapy (atoravastatin 40mg)
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Mar 21, 2023

Coronary Artery Calcification, Metabolic Syndrome, Dyslipidemias Trial (Guideline directed statin therapy, High intensity statin

Not yet recruiting
  • Coronary Artery Calcification
  • +2 more
  • Guideline directed statin therapy
  • High intensity statin plus ezetimibe therapy
  • (no location specified)
Apr 25, 2023

Diabetes, Pre Diabetes, ASCVD Trial (high-intensity statin arm, low-intensity statin plus ezetimibe)

Not yet recruiting
  • Diabetes Mellitus
  • +2 more
  • high-intensity statin arm
  • low-intensity statin plus ezetimibe
  • (no location specified)
Oct 12, 2022

Physical Activity Levels and Statin Therapy

Active, not recruiting
  • Cardiovascular Diseases
  • +2 more
  • Physical activity monitoring
  • Nijmegen, Netherlands
    Department of Physiology
Nov 15, 2022

Coronary Artery Diseasse Trial in Seoul (fixed high potent statin therapy, targeted LDL-C goal statin)

Active, not recruiting
  • Coronary Artery Diseasse
  • fixed high potent statin therapy
  • targeted LDL-C goal statin
  • Seoul, Korea, Republic of
    Division of Cardiology, Department of Internal Medicine, Yonsei
Jul 19, 2022

Diabetes, Type 2, Dyslipidemia Associated With Type II Diabetes, Statin Adverse Reaction Trial in Tunis (Atorvastatin 40 Mg Oral

Completed
  • Diabetes Mellitus, Type 2
  • +5 more
  • Atorvastatin 40 Mg Oral Tablet
  • Tunis, Tunisia
    University Hospital La Rabta
Apr 7, 2023

Atherosclerosis Trial in Essen (Medication management app (mediteo m+, Mediteo GmbH, Heidelberg))

Recruiting
  • Atherosclerosis
  • Medication management app (mediteo m+, Mediteo GmbH, Heidelberg)
  • Essen, Nordrhein-Westfalen, Germany
    University Hospital, Essen
Mar 8, 2023

Extra Alirocumab in Addition to Statin Therapy in Symptomatic

Recruiting
  • Stroke
  • Intracranial Atherosclerotic Stenosis
  • Nanjing, Jiangsu, China
    the First affiliated hospital of Nanjing Medical University
Sep 24, 2023

Doxorubicin Induced Cardiomyopathy Trial in Cairo (Atorvastatin 40 Mg Oral Tablet, Placebo)

Recruiting
  • Doxorubicin Induced Cardiomyopathy
  • Atorvastatin 40 Mg Oral Tablet
  • Placebo
  • Cairo, Egypt
    Ain Shams University hospitals
Apr 4, 2023

Coronary Artery Disease Trial in Boston (Rosuvastatin, Colchicine)

Not yet recruiting
  • Coronary Artery Disease
  • Boston, Massachusetts
    Massachusetts General Hospital
Apr 28, 2023

Combined Statin and PD-1/PD-L1 Inhibitors in Treating Non-small

Recruiting
  • Lung Cancer
  • Statin
  • Yiwu, Zhejiang, China
    The Fourth Affiliated Hospital of Zhejiang University
Dec 16, 2022

Intracranial Atherosclerosis, Atherosclerotic Plaque, Stenosis Trial in Nanjing (Alirocumab, Atorvastatin)

Not yet recruiting
  • Intracranial Atherosclerosis
  • +2 more
  • Nanjing, Jiangsu, China
    the First affiliated hospital of Nanjing Medical University
Oct 10, 2023

Quality of Life Trial in Tanta (Atorvastatin 20mg, Placebo)

Recruiting
  • Quality of Life
  • Atorvastatin 20mg
  • Placebo
  • Tanta, Egypt
    Tanta University
Nov 3, 2022

Status of Dyslipidemia Following Administration of Statin and

Recruiting
  • Dyslipidemias
  • Statin+Ezetimibe compound
  • Seoul, Korea, Republic of
    Korea University Guro Hospital
Nov 7, 2022

Primary Sclerosing Cholangitis, IBD Trial in Stanford (Rosuvastatin)

Recruiting
  • Primary Sclerosing Cholangitis
  • Inflammatory Bowel Diseases
  • Stanford, California
    Stanford University
Jun 12, 2023

Stroke Patients With Symptomatic Intracranial Atherosclerotic Stenosis Trial in Nanjing (Evolocumab, Atorvastatin)

Not yet recruiting
  • Stroke Patients With Symptomatic Intracranial Atherosclerotic Stenosis
  • Nanjing, Jiangsu, China
    the First affiliated hospital of Nanjing Medical University
Feb 14, 2023

Statin Treatment for Primary Prevention Trial in Bern (Statin discontinuation)

Not yet recruiting
  • Statin Treatment for Primary Prevention
  • Statin discontinuation
  • Bern, Switzerland
    University Hospital of Bern, University of Bern
Jul 28, 2022

Tuberculosis Trial in Johannesburg (Pravastatin)

Completed
  • Tuberculosis
  • Johannesburg, South Africa
    Chris Hani Baragwanath Hospital
Sep 26, 2022

Statin Treatment for Primary Prevention Trial in Bern (Statin discontinuation)

Recruiting
  • Statin Treatment for Primary Prevention
  • Statin discontinuation
  • Bern, Switzerland
    University Hospital of Bern, University of Bern
Aug 2, 2022

Acute Coronary Syndrome, Hyperlipidemias, Percutaneous Coronary Intervention Trial in Nanjing (Placebo plus high-intensity

Not yet recruiting
  • Acute Coronary Syndrome
  • +3 more
  • Placebo plus high-intensity statin
  • PCSK 9 Inhibitor plus high-intensity statin
  • Nanjing, Jiangsu, China
    Nanjing First Hospital
Aug 1, 2022

Atheroscleroses, Coronary Trial in Seoul (Rosuvastatin and Ezetimibe, Rosuvastatin)

Active, not recruiting
  • Atheroscleroses, Coronary
  • Seoul, Korea, Republic of
  • +1 more
Oct 1, 2022

Coronary Artery Disease, Dyslipidemias Trial in Yongin (a high dose of statin/ezetimib)

Recruiting
  • Coronary Artery Disease
  • Dyslipidemias
  • a high dose of statin/ezetimib
  • Yongin, Gyeonggi-do, Korea, Republic of
    Yongin Severance Hospital
Jun 14, 2023

Intracerebral Hemorrhage, Statins Trial in Beijing, Baoding (Statin)

Recruiting
  • Intracerebral Hemorrhage
  • Statins
  • Statin
  • Beijing, Beijing, China
  • +2 more
Jun 7, 2022